AAAAAA
Results: 1-25/69
Authors:
MIETTINEN HE
GYLLING H
TENHUNEN J
VIRTAMO J
JAUHIAINEN M
HUTTUNEN JL
KANTOLA I
MIETTINEN TA
KONTULA K
Citation: He. Miettinen et al., MOLECULAR-GENETIC STUDY OF FINNS WITH HYPOALPHALIPOPROTEINEMIA AND HYPERALPHALIPOPROTEINEMIA - A NOVEL GLY(230)ARG MUTATION (LCAT(FIN)) OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE (LCAT) ACCOUNTS FOR 5-PERCENT OF CASES WITH VERY-LOW SERUM HDL CHOLESTEROL LEVELS, Arteriosclerosis, thrombosis, and vascular biology, 18(4), 1998, pp. 591-598
Authors:
MIETTINEN TA
GYLLING H
STRANDBERG T
SARNA S
Citation: Ta. Miettinen et al., CHOLESTANOL AND SURVIVAL WITH SIMVASTATIN - REPLY, BMJ. British medical journal, 317(7167), 1998, pp. 1252-1253
Authors:
MIETTINEN TA
GYLLING H
STRANDBERG T
SARNA S
Citation: Ta. Miettinen et al., BASE-LINE SERUM CHOLESTANOL AS PREDICTOR OF RECURRENT CORONARY EVENTSIN SUBGROUP OF SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY, BMJ. British medical journal, 316(7138), 1998, pp. 1127-1130
Authors:
GYLLING H
VIRTANEN KS
SYVANNE M
MIETTINEN TA
Citation: H. Gylling et al., 2 YEARS OF LOW-DENSITY-LIPOPROTEIN APHERESIS IN FAMILIAL HYPERCHOLESTEROLEMIA - EFFECTS ON CHOLESTEROL-METABOLISM AND CORONARY-ARTERY DISEASE, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 8(3), 1998, pp. 164-171
Authors:
MIETTINEN TA
GYLLING H
Citation: Ta. Miettinen et H. Gylling, BASAL NON-CHOLESTEROL STEROLS REVEAL A SUBGROUP OF 4S NOT BENEFITED BY SIMVASTATIN-INDUCED DECREASE OF RECURRENT CORONARY EVENTS, Journal of the American College of Cardiology, 31(2), 1998, pp. 281-282
Authors:
GYLLING H
MIETTINEN TA
Citation: H. Gylling et Ta. Miettinen, SITOSTANOL ESTER ADDED TO LONG-TERM SIMVASTATIN TREATMENT OF CORONARYPATIENTS WITH LOW AND HIGH BASAL CHOLESTEROL ABSORPTION, Journal of the American College of Cardiology, 31(2), 1998, pp. 281-281
Authors:
KALLIO MJT
SALMENPERA L
SIIMES MA
PERHEENTUPA J
GYLLING H
MIETTINEN TA
Citation: Mjt. Kallio et al., THE APOLIPOPROTEIN-E PHENOTYPE HAS A STRONG INFLUENCE ON TRACKING OF SERUM-CHOLESTEROL AND LIPOPROTEIN LEVELS IN CHILDREN - A FOLLOW-UP-STUDY FROM BIRTH TO THE AGE OF 11 YEARS, Pediatric research, 43(3), 1998, pp. 381-385
Authors:
SARKKINEN ES
UUSITUPA MIJ
GYLLING H
MIETTINEN TA
Citation: Es. Sarkkinen et al., FAT-MODIFIED DIETS INFLUENCE SERUM CONCENTRATIONS OF CHOLESTEROL PRECURSORS AND PLANT STEROLS IN HYPERCHOLESTEROLEMIC SUBJECTS, Metabolism, clinical and experimental, 47(6), 1998, pp. 744-750
Authors:
LINDBOHM N
MIETTINEN TE
GYLLING H
MIETTINEN TA
Citation: N. Lindbohm et al., SIALIC-ACID CONTENT AND METABOLISM OF CHOLESTEROL AND LOW-DENSITY-LIPOPROTEIN IN MILD AND COMBINED HYPERLIPIDEMIA, Atherosclerosis (Amsterdam), 138, 1998, pp. 43-43
Authors:
GYLLING H
RIIKONEN S
NIKKILA K
SAVONIUS H
MIETTINEN TA
Citation: H. Gylling et al., ORAL GUAR GUM TREATMENT OF INTRAHEPATIC CHOLESTASIS AND PRURITUS IN PREGNANT-WOMEN - EFFECTS ON SERUM CHOLESTANOL AND OTHER NON-CHOLESTEROLSTEROLS, European journal of clinical investigation, 28(5), 1998, pp. 359-363
Authors:
VUORIO AF
GYLLING H
TURTOLA H
KONTULA K
MIETTINEN TA
Citation: Af. Vuorio et al., SITOSTANOL ESTER MARGARINE WITHOUT AND WITH SIMVASTATIN IN DIETARY-TREATMENT OR FAMILIES HETEROZYGOUS OF FAMILIAL HYPERCHOLESTEROLEMIA NORTH-KARELIA DELETION, Circulation, 98(17), 1998, pp. 2804-2804
Authors:
GYLLING H
MIETTINEN TA
Citation: H. Gylling et Ta. Miettinen, DIETARY STANOL ESTER IN STATIN-TREATED CORONARY PATIENTS WITH HIGH BASAL CHOLESTANOL VALUES, Circulation, 98(17), 1998, pp. 3079-3079
Authors:
RAJARATNAM RA
GYLLING H
MIETTINEN TA
Citation: Ra. Rajaratnam et al., SQUALENE AS A RISK FACTOR FOR CORONARY-ARTERY DISEASE IN WOMEN, Circulation, 98(17), 1998, pp. 3164-3164
Authors:
KOIVISTO UM
GYLLING H
MIETTINEN TA
KONTULA K
Citation: Um. Koivisto et al., FAMILIAL MODERATE HYPERCHOLESTEROLEMIA CAUSED BY ASP235-]GLU MUTATIONOF THE LDL RECEPTOR GENE AND COOCCURRENCE OF A DE-NOVO DELETION OF THE LDL RECEPTOR GENE IN THE SAME FAMILY, Arteriosclerosis, thrombosis, and vascular biology, 17(7), 1997, pp. 1392-1399
Authors:
MIETTINEN HE
JAUHIAINEN M
GYLLING H
EHNHOLM S
PALOMAKI A
MIETTINEN TA
KONTULA K
Citation: He. Miettinen et al., APOLIPOPROTEIN A-I-FIN (LEU159-]ARG) MUTATION AFFECTS LECITHIN - CHOLESTEROL ACYLTRANSFERASE ACTIVATION AND SUBCLASS DISTRIBUTION OF HDL BUT NOT CHOLESTEROL EFFLUX FROM FIBROBLASTS, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 3021-3032
Authors:
GYLLING H
KONTULA K
KOIVISTO UM
MIETTINEN HE
MIETTINEN TA
Citation: H. Gylling et al., POLYMORPHISMS OF THE GENES ENCODING APOPROTEIN-A-I, APOPROTEIN-B, APOPROTEIN-C-III, AND APOPROTEIN-E AND LDL-RECEPTOR, AND CHOLESTEROL AND LDL METABOLISM DURING INCREASED CHOLESTEROL INTAKE - COMMON ALLELES OFTHE APOPROTEIN-E GENE SHOW THE GREATEST REGULATORY IMPACT, Arteriosclerosis, thrombosis, and vascular biology, 17(1), 1997, pp. 38-44
Authors:
MIETTINEN HE
GYLLING H
MIETTINEN TA
VIIKARI J
PAULIN L
KONTULA K
Citation: He. Miettinen et al., APOLIPOPROTEIN A-I-FIN - DOMINANTLY INHERITED HYPOALPHALIPOPROTEINEMIA DUE TO A SINGLE-BASE SUBSTITUTION IN THE APOLIPOPROTEIN-A-I GENE, Arteriosclerosis, thrombosis, and vascular biology, 17(1), 1997, pp. 83-90
Authors:
GYLLING H
MIETTINEN TA
Citation: H. Gylling et Ta. Miettinen, TREATMENT OF LIPID DISORDERS IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Current opinion in lipidology, 8(6), 1997, pp. 342-347
Authors:
MIETTINEN TE
TARPILA S
GYLLING H
Citation: Te. Miettinen et al., THE EFFECTS OF URSODEOXYCHOLIC ACID ON SERUM AND BILIARY NONCHOLESTEROL STEROLS IN PATIENTS WITH GALLSTONES, Hepatology, 25(3), 1997, pp. 514-518
Authors:
VUORISTO M
FARKKILA M
GYLLING H
KARVONEN AL
LEINO R
LEHTOLA J
MAKINEN J
MATTILA J
TILVIS R
MIETTINEN TA
Citation: M. Vuoristo et al., EXPRESSION AND THERAPEUTIC RESPONSE RELATED TO APOLIPOPROTEIN-E POLYMORPHISM IN PRIMARY BILIARY-CIRRHOSIS, Journal of hepatology, 27(1), 1997, pp. 136-142
Authors:
GYLLING H
MIETTINEN TA
Citation: H. Gylling et Ta. Miettinen, CHOLESTEROL ABSORPTION, SYNTHESIS, AND LDL METABOLISM IN NIDDM, Diabetes care, 20(1), 1997, pp. 90-95
Authors:
KALLIO MJT
SALMENPERA L
SIIMES MA
PERHEENTUPA J
GYLLING H
MIETTINEN TA
Citation: Mjt. Kallio et al., APOPROTEIN E PHENOTYPE DETERMINES SERUM-CHOLESTEROL IN INFANTS DURINGBOTH HIGH-CHOLESTEROL BREAST-FEEDING AND LOW-CHOLESTEROL FORMULA FEEDING, Journal of lipid research, 38(4), 1997, pp. 759-764
THE EFFECTS OF FLUVASTATIN AND SIMVASTATIN ON SERUM-LIPIDS AND CHOLESTEROL ABSORPTION AND METABOLISM
Authors:
MIETTINEN TE
MIETTINEN TA
GYLLING H
Citation: Te. Miettinen et al., THE EFFECTS OF FLUVASTATIN AND SIMVASTATIN ON SERUM-LIPIDS AND CHOLESTEROL ABSORPTION AND METABOLISM, Atherosclerosis, 134(1-2), 1997, pp. 30-30
Authors:
SIMONEN P
GYLLING H
HOWARD AN
MIETTINEN TA
Citation: P. Simonen et al., WEIGHT-REDUCTION IMPROVES CHOLESTEROL ABSORPTION AND SYNTHESIS IN RELATION TO IMPROVED GLUCOSE-METABOLISM OF OBESE NIDDM PATIENTS, Atherosclerosis, 134(1-2), 1997, pp. 32-32
Authors:
MIETTINEN TA
GYLLING H
Citation: Ta. Miettinen et H. Gylling, BASAL NON-CHOLESTEROL STEROLS REVEAL A SUBGROUP OF 4S NOT BENEFITED BY SIMVASTATIN-INDUCED DECREASE OF RECURRENT CORONARY EVENTS, Atherosclerosis, 134(1-2), 1997, pp. 48-48